MENU

Japara Healthcare Ltd acquires Riviera Health residential aged care portfolio

Japara Healthcare Ltd (ASX: JHC) announced late on Monday that it has completed contracts to acquire the Riviera Health residential aged care portfolio. Management said that this builds on Japara’s strategy to grow through selective acquisitions that meet strict investment criteria and identifiable improvement opportunities.

The acquisition includes four aged care facilities at Brighton-Le-Sands, Chatswood, Doonside and Wyong. In the ASX release it said that the Brighton-Le-Sands facility is a newly-built 73 bed home, which is on course to open in August 2018. The Doonside facility is also new, it was built in 2017.

The acquisition also includes vacant possession of a closed aged care facility in Toukley on freehold land and 4.3 hectares of development land in Wyong.

The acquisition adds 507 bed licenses, 265 of which are currently operational.

Japara is building its presence in New South Wales and currently has five other facilities.

The net cash purchase price of Riviera is around $39 million and Japara will assume around $14.5 million of refundable accommodation deposits (RAD) and employee entitlement liabilities.

Management said that the cash purchase will be reduced to around $16 million as Japara expects to generate over $23 million from net RAD inflows from the nearly-completed Brighton-Le-Sands home over the next year and a half.

The acquisition will be funded from the company’s existing debt facility and cash reserves. Japara expects to add $3.5 million to $4 million of operating EBITDA in FY19 after integration into the Japara model.

Japara’s CEO, Mr Andrew Sudholz, said “We are pleased we were able to secure this highly value accretive acquisition opportunity…It provides Japara with an expanded footprint in high demand locations in New South Wales and an opportunity to further develop in these areas.”

Foolish takeaway

This seems like a good purchase by Japara and it’s a sizeable increase to the size of the business. The FY18 result will take a little hit with transaction costs, but it’s looking good for Japara’s medium-term and long-term future.

Along with Japara, one of these top stocks is also growing thanks to Australia’s ageing population.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Tristan Harrison owns shares of JAPARA DEF SET. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.